Drug‐Induced Liver Injury

作者: Leonard B. Seeff , Robert J. Fontana

DOI: 10.1002/9781444341294.CH24

关键词: Prescription drugDietary supplementPharmacogeneticsDrugMedicineRe challengeLatency (engineering)PharmacologyLiver injuryDrug metabolism

摘要:

参考文章(302)
Mohamad A. Eloubeidi, Jane T. Gaede, Mark W. Swaim, Reversible nefazodone-induced liver failure. Digestive Diseases and Sciences. ,vol. 45, pp. 1036- 1038 ,(2000) , 10.1023/A:1005558015787
C Andre, J C Homberg, N Abuaf, A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clinical and Experimental Immunology. ,vol. 55, pp. 561- 570 ,(1984)
Jean-Philippe Richardet, Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid. Digestive Diseases and Sciences. ,vol. 44, pp. 1997- 2000 ,(1999) , 10.1023/A:1026610015899
Hernandez Me, Ferrer Jp, Alberti-Flor Jj, Howell S, Jeffers L, Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim. The American Journal of Gastroenterology. ,vol. 84, pp. 1577- 1579 ,(1989)
Laura E Derby, Hershel Jick, David A Henry, Alan D Dean, Erythromycin‐Associated Cholestatic Hepatitis The Medical Journal of Australia. ,vol. 158, pp. 600- 602 ,(1993) , 10.5694/J.1326-5377.1993.TB137625.X
PI Pillans, Drug associated hepatic reactions in New Zealand: 21 years experience. The New Zealand Medical Journal. ,vol. 109, pp. 315- 319 ,(1996)
Andreas Büttner, Detlef Thieme, Side effects of anabolic androgenic steroids: pathological findings and structure-activity relationships. Handbook of experimental pharmacology. ,vol. 195, pp. 459- 484 ,(2010) , 10.1007/978-3-540-79088-4_19
HH Tan, WM Ong, SH Lai, WC Chow, Nimesulide-induced hepatotoxicity and fatal hepatic failure. Singapore Medical Journal. ,vol. 48, pp. 582- 585 ,(2007)
I. Colle, A. Elewaut, M. L. Hautekeete, H. Van Vlierberghe, Symptomatic liver injury probably related to sertraline. Gastroenterologie Clinique Et Biologique. ,vol. 22, pp. 364- 365 ,(1998)